Shivansh Sharma

Shivansh Sharma

Active Director Director DIN 07159961
DIN 07159961 First appointment Apr 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Total affiliations 6 Since Apr 2015
Shareholding value •••• Premium profile

About Shivansh Sharma

Data last updated:

Shivansh Sharma is a Director at Raymed Ophthalmic Private Limited (since 2019), Director at Raymed Pharmaceuticals Limited (since 2015) and Director at Aquavision Pharmaceuticals Private Limited (since 2020), and holds 3 more current directorships. The companies operate in Pharma, Healthcare and Chemicals and Materials. The 6 current companies with reported revenue have a combined latest revenue of ₹43.73 Cr; the largest is Raymed Ophthalmic Private Limited at ₹25.60 Cr (FY 2025).

DIN 07159961
Primary Designation Director
Industry Pharma
First Appointment 17 Apr 2015
Oldest Company Age 31 yrs
Largest company Raymed Ophthalmic Private Limited · ₹25.60 Cr (FY 2025)
Combined revenue ₹43.73 Cr across 6 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Raymed Ophthalmic Private Limited U24290CH2019PTC042483
Director02 May 20192019₹25.60 Cr (FY 2025)Active
Raymed Pharmaceuticals Limited U24231CH1995PLC015598
Director17 Apr 20151995₹14.90 Cr (FY 2025)Active
Director24 Sep 20202020₹2.38 Cr (FY 2025)Active
Raymzon Trade Links Private Limited U33100CH2020PTC043139
Director06 Aug 20202020₹56.9 Lakh (FY 2022)Active
Ayuray Organics Private Limited U74999CH2020PTC043070
Director08 Jul 20202020₹28 Lakh (FY 2025)Active
Director27 Jan 20202013₹3,216 (FY 2025)Active

Directorship timeline

Open interactive timeline →
Raymed Pharmaceuticals Limited
Raymed Ophthalmic Private Limited
Raymzon Trade Links Private Limited
Aquavision Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shivansh Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shivansh Sharma

Shivansh Sharma currently holds 6 directorships: Raymed Ophthalmic Private Limited (Director, since 02 May 2019, revenue ₹25.60 Cr (FY 2025)); Raymed Pharmaceuticals Limited (Director, since 17 Apr 2015, revenue ₹14.90 Cr (FY 2025)); Aquavision Pharmaceuticals Private Limited (Director, since 24 Sep 2020, revenue ₹2.38 Cr (FY 2025)); Raymzon Trade Links Private Limited (Director, since 06 Aug 2020, revenue ₹56.9 Lakh (FY 2022)); Ayuray Organics Private Limited (Director, since 08 Jul 2020, revenue ₹28 Lakh (FY 2025)); and 1 more.

Shivansh Sharma was first appointed on 17 Apr 2015 as Director at Raymed Pharmaceuticals Limited. The most recent appointment on record is 24 Sep 2020 at Aquavision Pharmaceuticals Private Limited.

The 6 current companies of Shivansh Sharma that report revenue have a combined latest revenue of ₹43.73 Cr: Raymed Ophthalmic Private Limited ₹25.60 Cr (FY 2025); Raymed Pharmaceuticals Limited ₹14.90 Cr (FY 2025); Aquavision Pharmaceuticals Private Limited ₹2.38 Cr (FY 2025); Raymzon Trade Links Private Limited ₹56.9 Lakh (FY 2022); Ayuray Organics Private Limited ₹28 Lakh (FY 2025); and 1 more.

The current boards of Shivansh Sharma's companies include Ashish Sachdeva (Raymed Ophthalmic Private Limited), Sanjay Jhamb (Raymed Ophthalmic Private Limited), Sanjiv Kumar Kansal (Raymed Ophthalmic Private Limited), Tarsem Kumar Ruby (Raymed Ophthalmic Private Limited), Veeta Sharma (Raymed Pharmaceuticals Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available